| |
 |
ARTICLES 
|
|
| Hematopoietic growth factors and high-dose chemotherapy: will grams succeed where milligrams fail? |
| GD Demetri and JD Griffin |
|
JCO May 1 1990: 761–764.
[PDF]
|
 |
| Detecting bleomycin pulmonary toxicity: a continued conundrum |
| RL Comis |
|
JCO May 1 1990: 765–767.
[PDF]
|
|
|
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high- dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma |
| |
AM Gianni, M Bregni, S Siena, A Orazi, AC Stern, L Gandola, and G Bonadonna |
| |
JCO May 1 1990: 768–778.
[Abstract]
[PDF]
|
|
|
Carbon monoxide diffusing capacity is a poor predictor of clinically significant bleomycin lung. New Zealand Clinical Oncology Group |
| |
MJ McKeage, BD Evans, C Atkinson, D Perez, GV Forgeson, and PJ Dady |
| |
JCO May 1 1990: 779–783.
[Abstract]
[PDF]
|
|
|
Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse |
| |
AS Freedman, T Takvorian, KC Anderson, P Mauch, SN Rabinowe, K Blake, B Yeap, R Soiffer, F Coral, and L Heflin |
| |
JCO May 1 1990: 784–791.
[Abstract]
[PDF]
|
|
|
A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression |
| |
DA Scheinberg, DJ Straus, SD Yeh, C Divgi, P Garin-Chesa, M Graham, K Pentlow, D Coit, HF Oettgen, and LJ Old |
| |
JCO May 1 1990: 792–803.
[Abstract]
[PDF]
|
|
|
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients |
| |
G Todeschini, A Ambrosetti, V Meneghini, G Pizzolo, F Menestrina, M Chilosi, F Benedetti, D Veneri, GL Cetto, and G Perona |
| |
JCO May 1 1990: 804–808.
[Abstract]
[PDF]
|
|
|
Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission |
| |
X Troussard, V Leblond, M Kuentz, N Milpied, JP Jouet, C Cordonnier, M Leporrier, and JP Vernant |
| |
JCO May 1 1990: 809–812.
[Abstract]
[PDF]
|
|
|
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia |
| |
BD Cheson, PA Cassileth, DR Head, CA Schiffer, JM Bennett, CD Bloomfield, R Brunning, RP Gale, MR Grever, and MJ Keating |
| |
JCO May 1 1990: 813–819.
[Abstract]
[PDF]
|
|
|
Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia |
| |
JR Wingard, S Piantadosi, GW Santos, R Saral, HM Vriesendorp, AM Yeager, WH Burns, RF Ambinder, HG Braine, and G Elfenbein |
| |
JCO May 1 1990: 820–830.
[Abstract]
[PDF]
|
|
|
Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance |
| |
G Schlimok, I Funke, B Bock, B Schweiberer, J Witte, and G Riethmuller |
| |
JCO May 1 1990: 831–837.
[Abstract]
[PDF]
|
|
|
Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program |
| |
C Jacobs and R Makuch |
| |
JCO May 1 1990: 838–847.
[Abstract]
[PDF]
|
|
|
Immunosuppressive effects of pentostatin |
| |
EH Kraut, JC Neff, BA Bouroncle, D Gochnour, and MR Grever |
| |
JCO May 1 1990: 848–855.
[Abstract]
[PDF]
|
|
|
Active-specific immunotherapy for melanoma |
| |
MS Mitchell, W Harel, RA Kempf, E Hu, J Kan-Mitchell, WD Boswell, G Dean, and L Stevenson |
| |
JCO May 1 1990: 856–869.
[Abstract]
[PDF]
|
|
|
Predictive initial parameters for response of stage D prostate cancer to treatment with the luteinizing hormone-releasing hormone agonist goserelin |
| |
W Kreis, FR Ahmann, M Lesser, M Scott, R Caplan, T Gau, and V Vinciguerra |
| |
JCO May 1 1990: 870–874.
[Abstract]
[PDF]
|
|
|
Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II study |
| |
K Hoffken, W Jonat, K Possinger, M Kolbel, T Kunz, H Wagner, R Becher, R Callies, P Friederich, and W Willmanns |
| |
JCO May 1 1990: 875–880.
[Abstract]
[PDF]
|
|
|
Phase II trial of interferon-beta-serine in metastatic renal cell carcinoma |
| |
P Kinney, P Triozzi, D Young, J Drago, B Behrens, H Wise, and JJ Rinehart |
| |
JCO May 1 1990: 881–885.
[Abstract]
[PDF]
|
|
|
Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial |
| |
DW Luedke, L Einhorn, GA Omura, PR Sarma, AA Bartolucci, R Birch, and FA Greco |
| |
JCO May 1 1990: 886–891.
[Abstract]
[PDF]
|
|
|
Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study |
| |
JD McCracken, LM Janaki, JJ Crowley, SA Taylor, PG Giri, GB Weiss, W Gordon, Jr, LH Baker, A Mansouri, and JP Kuebler |
| |
JCO May 1 1990: 892–898.
[Abstract]
[PDF]
|
|
|
Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer |
| |
IE Smith, TJ Perren, SA Ashley, J Woodiwiss, GV Forgeson, JR Yarnold, and HT Ford |
| |
JCO May 1 1990: 899–905.
[Abstract]
[PDF]
|
|
|
Failure of 1H nuclear magnetic resonance spectroscopy of blood plasma to detect malignancy |
| |
P Okunieff, MD Greenberg, A Zietman, J Kahn, S Westgate, and LJ Neuringer |
| |
JCO May 1 1990: 906–910.
[Abstract]
[PDF]
|
|
|
Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors [published erratum appears in J Clin Oncol 1990 Aug;8(8):1447] |
| |
EE Vokes and RR Weichselbaum |
| |
JCO May 1 1990: 911–934.
[Abstract]
[PDF]
|
|
| The new International Neuroblastoma Staging System: some critical notes |
| NL Carlsen |
|
JCO May 1 1990: 935–936.
[PDF]
|
|
| Intensive therapy in elderly patients with acute myeloid leukemia |
| PA Cassileth |
|
JCO May 1 1990: 937–938.
[PDF]
|
|
| Toxicity of etoposide, doxorubicin, and cisplatin in gastric cancer |
| JA Sparano and PH Wiernik |
|
JCO May 1 1990: 938–939.
[PDF]
|
|
| EAP in advanced gastric cancer |
| BG Taal, WW ten Bokkel Huinink, H Franklin, and S Rodenhuis |
|
JCO May 1 1990: 939–941.
[PDF]
|
|
| To lap or not to lap |
| TE Goffman and E Glatstein |
|
JCO May 1 1990: 941–942.
[PDF]
|
|
| Contrast medium "recalls" interleukin-2 toxicity |
| RK Oldham, J Brogley, and E Braud |
|
JCO May 1 1990: 942–943.
[PDF]
|
|
